Joel A. Okoli to Humans
This is a "connection" page, showing publications Joel A. Okoli has written about Humans.
Connection Strength
0.114
-
Bumpers HL, Tadros T, Gabram-Mendola S, Rizzo M, Martin M, Zaremba N, Okoli J. Phyllodes tumors in African American women. Am J Surg. 2015 Jul; 210(1):74-9.
Score: 0.025
-
Barrett G, Seniors R, Okoli J, Chase A, Henry B, Mubasher M, Turner J. Validation of Use of Flipped Classroom for Surgery Core Clerkships. J Surg Educ. 2022 May-Jun; 79(3):668-675.
Score: 0.010
-
White BN, Okoli J, Dixon JB, Yuan L, Yang S, Gabram-Mendola SGA. Use of a portable infrared 3D scanning device measuring limb volume in a safety net hospital breast clinic. Breast J. 2021 06; 27(6):559-561.
Score: 0.010
-
White BN, Lu IM, Kao LS, Dixon JB, Weiler MJ, Frank ND, Binkley J, Subhedar P, Okoli J, Buhariwalla K, Suarez-Ligon A, Gabram-Mendola SGA. An infrared 3D scanning device as a novel limb volume measurement tool in breast cancer patients. World J Surg Oncol. 2020 Oct 27; 18(1):278.
Score: 0.009
-
Binkley JM, Stratford P, Kirkpatrick S, Farley CR, Okoli J, Gabram S. Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery. Clin Breast Cancer. 2018 12; 18(6):e1261-e1267.
Score: 0.008
-
Lai L, Binkley J, Jones V, Kirkpatrick S, Furbish C, Stratford P, Thompson W, Sidhu A, Farley C, Okoli J, Beech D, Gabram S. Implementing the Prospective Surveillance Model (PSM) of Rehabilitation for Breast Cancer Patients with 1-Year Postoperative Follow-up, a Prospective, Observational Study. Ann Surg Oncol. 2016 10; 23(10):3379-84.
Score: 0.007
-
Jones V, Linebarger J, Perez S, Gabram S, Okoli J, Bumpers H, Burns B, Mosunjac M, Rizzo M. Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital. Ann Surg Oncol. 2016 Feb; 23(2):456-64.
Score: 0.007
-
Bumpers HL, Gabram-Mendola S, Okoli J, Rizzo M. Image of the month. Locally advanced breast cancer. JAMA Surg. 2013 Mar; 148(3):297-8.
Score: 0.006
-
Bowman E, Oprea G, Okoli J, Gundry K, Rizzo M, Gabram-Mendola S, Manne U, Smith G, Pambuccian S, Bumpers HL. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J. 2012 May-Jun; 18(3):242-7.
Score: 0.005
-
Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O'Regan R, Zelnak A, Pan L, Mosunjac M, Patterson SG, Gabram SG. Improving on national quality indicators of breast cancer care in a large public hospital as a means to decrease disparities for African American women. Ann Surg Oncol. 2011 Jan; 18(1):34-9.
Score: 0.005
-
Iyengar R, Lund MJ, Lamson P, Holmes L, Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O'Regan R, Gabram SG. Using National Quality Forum breast cancer indicators to measure quality of care for patients in an AVON comprehensive breast center. Breast J. 2010 May-Jun; 16(3):240-4.
Score: 0.005
-
Lund MJ, Butler EN, Bumpers HL, Okoli J, Rizzo M, Hatchett N, Green VL, Brawley OW, Oprea-Ilies GM, Gabram SG. High prevalence of triple-negative tumors in an urban cancer center. Cancer. 2008 Aug 01; 113(3):608-15.
Score: 0.004
-
Gabram SG, Lund MJ, Gardner J, Hatchett N, Bumpers HL, Okoli J, Rizzo M, Johnson BJ, Kirkpatrick GB, Brawley OW. Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer. 2008 Aug 01; 113(3):602-7.
Score: 0.004
-
Crump SR, Shipp MP, McCray GG, Morris SJ, Okoli JA, Caplan LS, Thorne SL, Blumenthal DS. Abnormal mammogram follow-up: do community lay health advocates make a difference? Health Promot Pract. 2008 Apr; 9(2):140-8.
Score: 0.004
-
Bumpers HL, Huang MB, Powell M, Grizzle WE, Lillard JW, Okoli J, Bond VC. Effects of HIV-1 Nef, a cytotoxic viral protein, on the growth of primary colorectal cancer. Cancer Biol Ther. 2005 Jan; 4(1):65-9.
Score: 0.003
-
Aikhionbare FO, Khan M, Carey D, Okoli J, Go R. Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol Cancer. 2004 Oct 13; 3:30.
Score: 0.003